Fosrolapitant and Palonosetron for the Prevention of Antibody-drug Conjugate-induced Nausea and Vomiting
Clinical trial NCT07692451 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07692451
- Sponsor
- Peking University Cancer Hospital & Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2027-07-15
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.